Articles tagged with Pancreatic Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers found erlotinib to effectively block EGFR, improving survival in patients with pancreatic cancer. In vitro studies revealed erlotinib's ability to repress cell growth, induce apoptosis, and suppress angiogenesis.
Researchers found that serum CA19-9 levels correlate with TNM staging and tumor size in patients with pancreatic cancer. The study used ROC curve analysis to evaluate the clinical value of serum CA19-9 levels in predicting respectability, revealing a high accuracy of 93.1% sensitivity and 78.3% specificity.
Two novel histone deacetylase inhibitors, NVP-LBH589 and NVP-LAQ824, have been shown to suppress the growth of human pancreatic cancer cells and induce apoptosis in vitro and in vivo. Further studies are recommended for their potential treatment.
Researchers found that ellagic acid increases programmed cell death and decreases proliferation of pancreatic cancer cells. The compound also reduces the activity of the pro-survival transcription factor NF-kB, which may help overcome resistance to radio and chemotherapies.
Researchers developed a 'suicide gene' delivery approach that successfully kills pancreatic cancer cells by over 95 percent, targeting only cancer cells with minimal harm to normal ones. This innovative strategy uses mesothelin DNA linked to diphtheria toxin, effectively hijacking cancer cell machinery.
Researchers found that mirtazapine increased appetite and reversed weight loss, while fluoxetine suppressed food intake and promoted weight loss. These antidepressants had no effect on pancreatic tumor growth.
Researchers at Georgetown University Medical Center found that CyberKnife radiosurgery is a safe treatment option for recurrent pancreatic cancer, allowing patients to resume systemic chemotherapy quickly. The study demonstrated acceptable safety and efficacy in delivering treatment within a week's time.
Researchers found that a twice-weekly gemcitabine infusion schedule improved median survival time, disease-free survival time, and overall 1-year survival rate compared to previous studies. The study also showed that patients with reduced tumor markers had better prognosis.
A new chemotherapy drug combination has shown excellent results in a phase II trial, extending median survival time in patients with inoperable pancreatic cancer by up to 6.4 months compared to standard therapy. The treatment, EndoTAG-1, destroys new blood vessels around tumors, improving patient outcomes.
Researchers report that endoscopic ultrasound (EUS) is highly accurate in diagnosing pancreatic neoplasms, with a 99.1% accuracy rate. EUS-FNA also shows excellent results, with 88.8% sensitivity and 100% specificity, making it an ideal next step for patients with ambiguous imaging findings.
Researchers at VCU Massey Cancer Center have developed a gene therapy approach that eliminates human pancreatic cancer cells in mice. The therapy combines perillyl alcohol, a natural compound found in citrus plants, with mda-7/IL-24 cytokine to kill aggressive and lethal cancer cells.
A new study from Northwestern University found that cancer patients treated at high-volume hospitals have more lymph nodes examined for cancer spread, leading to improved long-term outcomes. This increased nodal evaluation can accurately diagnose stage disease and predict patient prognosis.
Patients with gastric or pancreatic cancer treated at high-volume hospitals or comprehensive cancer centers receive more thorough lymph node evaluations. This practice is associated with better prognosis and treatment decisions for these patients.
Researchers found overexpression of TG2 in ovarian cancer to be associated with increased tumor cell growth, adhesion, resistance to chemotherapy, and lower overall survival rates. Silencing TG2 using siRNA reversed cancer progression, suggesting the protein as a novel therapeutic approach for late-stage ovarian cancer.
Researchers from Fred Hutchinson Cancer Research Center identified five proteins that may be useful tools in detecting early-stage pancreatic tumors. The panel of proteins discriminated between pancreatic cancer cases and controls in blood specimens, suggesting a potential role in early detection.
Researchers identified five biomarkers linked to early development of pancreatic cancer in mice that also apply to early stages in humans. These findings bring scientists closer to developing a blood test to detect the disease early, when cure rates are highest.
Researchers at UPMC Cancer Institute have developed a new treatment combination that combines chemotherapy, biotherapy, and radiotherapy to treat pancreatic cancer. The study found that this regimen is safe and may be beneficial for patients, with significant tumor shrinkage before surgery.
A randomized phase II study found a trend towards increased survival in patients with advanced pancreatic cancer treated with axitinib plus gemcitabine compared to gemcitabine alone. The median overall survival was longer in the axitinib group, but the finding requires further investigation in a phase III trial.
Research found that individuals with gum disease have an increased risk of various cancers, including lung, kidney, and pancreatic cancers. Gum disease was associated with a 14% higher overall cancer risk compared to those without gum disease.
Researchers at OHSU have developed new antibodies that can recognize pancreatic cancer and gastrointestinal cancers. These antibodies show promise in early detection and treatment of pancreatic cancer, which is the fourth-leading cause of cancer death in the US.
Researchers found that endoscopic ultrasound improves patient outcomes after diagnosis with pancreatic cancer. Heavy smoking and drinking are linked to an earlier onset of the disease, with beer being the strongest contributor.
GAL-3 stimulates pancreatic stellate cell activation, which promotes the proliferation and invasion of pancreatic cancer cells. This interaction provides a new therapeutic target for controlling pancreatic cancer.
Researchers found that thymoquinone blocked pancreatic cancer cell growth and killed cells by enhancing programmed cell death, with 80% of cancer cells killed. Thymoquinone also triggered epigenetic changes, including acetylation of histones, which could lead to new cancer treatments.
The University of Pittsburgh Cancer Institute has established a groundbreaking BRCA cancer research program focusing on genetic mutations that significantly increase breast, prostate, ovarian, and pancreatic cancer risks. The program aims to identify innovative ways to reduce the risk for high-risk patients.
Researchers found that calorie restriction hinders development of pancreatic cancer by reducing levels of IGF-1 and inflammatory signaling proteins. Only 7.5% of mice on the calorie-restricted diet developed lesions, compared to 45% and 57.5% in overweight and obese groups.
Two new therapies have shown promising results in treating basal cell carcinoma and pancreatic cancer. A novel molecule, GDC-0449, has been found to shrink tumors with limited side effects, while a combination of two drugs has shown significant clinical benefit in over 80% of pancreatic cancer patients.
Researchers present data on the preventive effects of celecoxib and atorvastatin in colorectal, prostate and breast cancer. The study found that patients taking celecoxib had a significant reduction in adenomas, precursor to colon cancer, with low cardiovascular risk. A combination of atorvastatin and celecoxib also inhibited the growt...
Researchers at Thomas Jefferson University have found that common blood pressure medications can inhibit pancreatic cancer cell growth and cause cell death. The study suggests that these drugs may be part of a novel strategy to control the growth and spread of cancer.
Researchers found that nicotine increases osteopontin production, promoting cancer cell survival and spread. Elevated osteopontin levels have been detected in pancreatic cancer patients, suggesting a potential role in the cigarette smoking-pancreatic cancer connection.
A study found that adding gemcitabine to chemoradiation improved survival rates for pancreatic cancer patients who had surgery, but the benefit was not statistically significant. The treatment reduced local relapse and systemic metastasis in patients.
Researchers have discovered that heart hormones can eliminate human pancreatic and breast cancers in mice, reducing tumors by up to 97%. The treatment has shown no side effects and has the potential to make cancer a chronic condition.
Researchers at Baylor College of Medicine discovered that mesothelin, a protein found on tumor cells' surface, promotes pancreatic cancer growth. A new vaccine targeting mesothelin, made from virus-like particles, has shown promise in slowing tumor growth and increasing survival time in mice.
A new study by Saint Louis University researchers found a striking correlation between patient prognosis and tumor size at diagnosis. Patients with tumors under 20mm had the highest median survival rates, but only accounted for 18% of cases.
Scientists discovered that metastatic pancreatic cancer cells produce enough of the protein IDO to evade detection by the immune system, allowing them to spread in the body. This finding may lead to new ways to detect pancreatic cancer spreading to lymph nodes and enhance tumor immune therapy strategies.
Researchers found that ZIP4, a zinc transporter, is overexpressed in pancreatic cancer tissue and promotes tumor growth. The study provides a potential diagnostic marker and candidate for cancer vaccine development.
Researchers present emerging therapies targeting cancer cells, including a small molecule inhibitor of protein kinase D and an oncolytic herpes virus that selectively targets cancer cells without damaging nerves. These treatments offer promising methods for controlling disease and improving patient outcomes.
A study found that diabetes increases levels of CA 19-9, a tumor marker for pancreatic cancer. Elevated CA 19-9 levels in diabetics may indicate chronic pancreatitis rather than pancreatic cancer.
Researchers at Jefferson University have discovered a tumor-blocking protein, pp32, that may be missing in aggressive forms of pancreatic cancer. The absent protein could eventually serve as a biomarker for the disease and a potential therapeutic target.
Eating flavonol-rich foods like apples may help reduce pancreatic cancer risk, with quercetin identified as a key compound. Smokers who consumed more flavonols had a significantly greater risk reduction.
A new study found that gemcitabine chemotherapy after surgery doubles disease-free survival from 4.9 to 11.4 months in patients with operable pancreatic cancer, improving outcomes by 41 percent
Researchers identified a distinct subpopulation of cancer stem cells responsible for metastasis in human pancreatic cancer. The study found that CSCs expressing CD133 and CXCR4 play a critical role in tumor metastasis, and inhibiting these cells or transplanting non-metastatic cells can abolish metastatic tumor development.
Researchers at the University of Georgia are working on a new approach to detect pancreatic cancer using subtle changes in proteins and sugars. They believe that these biomarkers can be found in pancreatic fluid and blood, which could lead to earlier detection and improved treatment outcomes.
Researchers found a blood protein, IGFBP-1, linked to obesity and exercise aversion may indicate increased pancreatic cancer risk. The study suggests lifestyle factors modifiable for improved prognosis.
Researchers found that people with low IGFBP-1 levels were twice as likely to develop pancreatic cancer as those with higher levels. This protein's role in modulating insulin and IGF hormones may hold clues to the disease's development, potentially aiding in risk prediction.
Research suggests women with a history of gestational diabetes are at higher risk of developing pancreatic cancer. A study of over 37,000 mothers who gave birth in Jerusalem between 1964 and 1976 found five cases of pancreatic cancer among those with gestational diabetes.
A new optical technology has been developed to detect early signs of pancreatic cancer, allowing for earlier diagnosis and potentially improving treatment outcomes. The technique uses a minimally invasive procedure that can identify cancerous tissue with high accuracy, even in patients with chronic pancreatitis or family history.
Researchers developed a novel technology using light to probe tissue architecture, enabling subtle changes in tissue to be detected. The technique produced an optic fingerprint from altered tissue, distinguishing patients with cancer at an accuracy approaching 100 percent.
Researchers found that nimesulide, a COX-2 inhibitor, delayed the development of precancerous pancreatic lesions in mice by 90%, potentially offering a new approach to preventing pancreatic cancer in high-risk populations. The study suggests that inhibiting COX-2 may help slow or prevent the progression of pancreatic cancer.
A Northwestern University-developed optical technology has been found to be effective in the early detection of colon cancer, now appearing promising for detecting pancreatic cancer. The technique can detect abnormal changes in cells lining the duodenum without touching or imaging the pancreas.
Researchers have identified IL6 as a protein that stimulates tumor growth when activated by Ras, leading to increased blood vessel formation. Suppressing IL6 activity has shown promising results in fighting tumor formation in preclinical models.
Researchers at the University of Texas M. D. Anderson Cancer Center have developed a gene therapy that selectively targets and eliminates pancreatic cancer cells, inhibiting metastasis and prolonging survival with minimal toxicity. The therapy, called VISA-BikDD, has shown significant promise in preclinical trials, with treated mice su...
A study led by University of Cincinnati scientists has found that the RON receptor is overexpressed in pancreatic cancer cells, suggesting a link between the receptor and disease development. The researchers believe blocking the receptor's signaling pathways could lead to new therapies for this deadly disease.
Scientists create a new adenovirus that selectively targets cancer cells with high dNTP concentrations, potentially delivering genetic materials to destroy malignant cells. The approach has shown promise in testing mice and human pancreatic cancer cells.
Researchers found that consuming high amounts of vitamin B6, B12, and folate from food reduced the risk of pancreatic cancer by 59%, 73%, and 81% respectively. In contrast, multivitamin use was associated with a higher risk of developing the disease.
A recent study evaluated the incidence of malignancy in small pancreatic tumors and identified predictors such as age, gender, symptoms, and radiographic features. The findings suggest that very small tumors with no other symptoms or radiographic indicators have a low risk of malignancy.
Recent research evaluates the progress made to date in diagnosing and treating pancreatic cancer, highlighting promising new applications of technology that will improve survival rates. The studies also identify key predictors of malignancy, including age, gender, symptoms, and radiographic features.
A large cohort study found that using Swedish moist snuff (snus) increases the risk of developing pancreatic cancer by twice the rate of non-users. The study, conducted on almost 300,000 male construction workers, suggests that while the risks are small, snus use can still be a concern for overall health.
A recent study published in The Lancet found that Swedish snus is associated with a higher risk of pancreatic cancer, despite being less harmful than smoking. However, switching from cigarettes to snus can potentially lead to significant health benefits for smokers.
Researchers at Ohio State University Comprehensive Cancer Center have discovered a way to distinguish pancreatic cancer from non-cancerous tissue using microRNA molecules. The study found that specific miRNAs can predict patient survival rates, with correlations seen in just a few miRNAs that were not previously associated with the dis...
A new study identified genetic markers that can distinguish between chronic pancreatitis and pancreatic cancer, as well as predict patient outcomes. The discovery represents a significant advancement in cancer diagnostics and may lead to improved therapy options.